InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
T+90 hit rate
80%
T+90 mean return
+1.7%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Fonseca Lidia, Chairman & CEO. Insider active across 3 companies, notably TEGNA INC. Aggregated, 10 disclosures have been published. Activity tracked since 31 January 2022. The latest transaction was disclosed on 28 April 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations10 total
2,083 shares@ US$84.0433.1% of flowOrdinary SharesSEC:0001613103-25-000064:0
72,629 shares@ US$31.3177.5% of flowCommon StockSEC:0001225208-25-002704:0
162 shares@ US$80.892.6% of flowOrdinary SharesSEC:0001613103-24-000048:0
2,165 shares@ US$80.8635.3% of flowOrdinary SharesSEC:0001613103-24-000029:0
1,624 shares@ US$90.6829.0% of flowOrdinary SharesSEC:0001613103-23-000026:0
6,039.39 sharesCommon StockSEC:0001214659-23-006352:0
6,680 shares@ US$52.690.0002% mcap50.0% of flowCommon StockSEC:0001225208-22-001256:0
6,680 shares@ US$52.690.0002% mcap100.0% of flowCommon StockSEC:0001225208-22-001256
10,410 sharesCommon StockSEC:0001214659-21-004902
10,410 sharesCommon StockSEC:0001214659-21-004902:0
10 of 10 declarations
About Fonseca Lidia
Lidia Fonseca is the CEO & Executive Vice President at TEGNA INC and Pfizer Inc. She oversees the strategic and business operations of both companies, focusing on innovation and growth. Her role is crucial for developing new initiatives and optimizing TEGNA and Pfizer's performance in their respective sectors.
